Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition

Vaccine-Related Journal Articles

Diseases and Vaccines: Meningococcus

Anthrax HPV Pertussis Rubella
Chickenpox (varicella) Influenza (variant) PCV Shingles (zoster)
Diphtheria Influenza (seasonal) PPSV Smallpox
Hepatitis A Measles Polio Tetanus
Hepatitis B Meningococcus Rabies
Hib Mumps Rotavirus
Meningococcus archive 2003-1997
Meningococcus 2014-2013
Fatal Meningococcal Disease in a Laboratory Worker—California, 2012
Source: MMWR, September 5, 2014, Vol. 63(35):770-2
HTML
Updated Recommendations on the Use of Meningococcal Vaccines
Authors: AAP Committee on Infectious Diseases
Source: Pediatrics, e-published July 28, 2014
Abstract
National, Regional, State, and Selected Local Area Vaccination Coverage among Adolescents Aged 13–17 Years—United States, 2013
Source: MMWR, July 25, 2014, Vol. 63(29):625-33
HTML
Use of MenACWY-CRM Vaccine in Children Aged 2 through 23 Months at Increased Risk for Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2013
Source: MMWR, June 20, 2014, Vol. 63(24):527-30
HTML
Antibody Persistence after Primary and Booster Doses of a Quadrivalent Meningococcal Conjugate Vaccine in Adolescents
Authors: Baxter R, Reisinger K, Block SL, Percell S, Odrljin T, Dull PM, Smolenov I
Source: Pediatr Infect Dis J, e-published June 6, 2014
Abstract
Antibody Persistence and Booster Response of a Quadrivalent Meningococcal Conjugate Vaccine in Adolescents
Authors: Baxter R, Reisinger K, Block SL, Izu A, Odrljin T, Dull P
Source: J Pediatr, e-published March 14, 2014
Abstract
National and State Vaccination Coverage among Adolescents Aged 13–17 Years — United States, 2012
Source: MMWR, August 30, 2013, Vol. 62(34):685-93
HTML
Antibody Persistence and Response to a Booster Dose of a Quadrivalent Conjugate Vaccine for Meningococcal Disease in Adolescents
Authors: Jacobson RM, Jackson LA, Reisinger K, Izu A, Odrljin T, Dull PM
Source: Pediatr Infect Dis J, April 2013, Vol. 32(4):e170-7
Abstract
Reasons for Not Vaccinating Adolescents: National Immunization Survey of Teens, 2008-2010
Authors: Darden PM, Thompson DM, Roberts JR, Hale JJ, Pope C, Naifeh M, Jacobson RM
Source: Pediatrics, April 2013, Vol. 131(4):645-51
Abstract
Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale
Source: MMWR, January 25, 2013, Vol. 62(03):52-4
HTML
back to top
Meningococcus 2012
National and State Vaccination Coverage Among Adolescents Aged 13–17 Years--United States, 2011
Source: MMWR, August 31, 2012, Vol. 61(34):671-7
HTML
Comparison of Meningococcal Disease Surveillance Systems--United States, 2005-2008
Source: MMWR, May 4, 2012, Vol. 61(17):306-8
HTML
Outbreak of Meningococcal Disease Associated with an Elementary School--Oklahoma, March 2010
Source: MMWR, April 6, 2012, Vol. 61(13):217-21
HTML
Update on Adult Immunizations
Author: Wolfe RM
Source: J Am Board Fam Med, 2012, Vol. 25(4):496-510
Available online at: www.jabfm.org/content/25/4/496.full
back to top
Meningococcus 2011
Recommendation of the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) among Children Aged 9 through 23 Months at Increased Risk for Invasive Meningococcal Disease
Source: MMWR, October 14, 2011, Vol. 60(40):1391-2
HTML
National and State Vaccination Coverage among Adolescents Aged 13 Through 17 Years--United States, 2010
Source: MMWR, August 26, 2011, Vol. 60(33):1117-23
HTML
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease--Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 5, 2011, Vol. 60(30):1018-9
HTML
Updated Recommendations for Use of Meningococcal Conjugate Vaccines--Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, January 28, 2011, Vol. 60(03):72-6
HTML
back to top
Meningococcus 2010
Changes in Tdap and MCV4 Vaccine Coverage following Enactment of a Statewide Requirement of Tdap Vaccination for Entry into Sixth Grade
Authors: Kharbanda EO, Stockwell MS, Colgrove J, Natarajan K, Rickert VI
Source: Am J Public Health, September 2010, Vol. 100(9):1635-40
Abstract
National, State, and Local Area Vaccination Coverage among Adolescents Aged 13-17 Years--United States, 2009
Source: MMWR, August 20, 2010, Vol. 59(32):1018-23
HTML
Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use--Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, March 12, 2010, Vol. 59(09):273
HTML
back to top
Meningococcus 2009
Meningococcal Conjugate Vaccination among Adolescents Aged 13-17 Years, United States, 2007
Authors: Lu PJ, Jain N, Cohn AC
Source: Vaccine, December 28, 2009
Abstract
Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Revaccination of Persons at Prolonged Increased Risk for Meningococcal Disease
Source: MMWR, September 25, 2009, Vol. 58(37):1042-3
HTML  PDF (entire issue)
National, State, and Local Area Vaccination Coverage among Adolescents Aged 13-17 Years--United States, 2008
Source: MMWR, September 18, 2009, Vol. 58(36):997-1001
HTML  |  PDF (entire issue)
Immunization Programs for Infants, Children, Adolescents, and Adults: Clinical Practice Guidelines by the Infectious Diseases Society of America
Authors: Pickering LK, Baker CJ, Freed GL, et al.
Source: Clin Infect Dis, September 15, 2009, Vol. 49(6):817-40
Abstract
Increasing Adolescent Vaccination: Barriers and Strategies in the Context of Policy, Legal, and Financial Issues
Authors: Ford CA, English A, Davenport AF, Stinnett AJ
Source: J Adolesc Health, June 2009, Vol. 44(6):568-74
Abstract
State-Based Surveillance to Determine Trends in Meningococcal Disease
Authors: Clarke C, Mallonee S
Source: Public Health Rep, March-April 2009, Vol. 124(2):280-7
Abstract
Outcomes of Meningococcal Disease in Adolescence: Prospective, Matched-Cohort Study
Authors: Borg J, Christie D, Coen P, Booy R, Viner R
Source: Pediatrics, March 2009, Vol. 123(3):e502-509
Abstract
Completeness and Timeliness of Reporting of Meningococcal Disease--Maine, 2001-2006
Source: MMWR, February 27, 2009, Vol. 58(07):169-172
HTML  |  PDF (entire issue)
back to top
Meningococcus 2008-2007
Meningococcal Tetravalent Conjugate Vaccine
Author: Smith MJ
Source: Expert Opin Biol Ther, December 2008, Vol. 8(12):1941-6
Abstract
Report from the Advisory Committee on Immunization Practices (ACIP): Decision Not to Recommend Routine Vaccination of All Children Aged 2-10 Years with Quadrivalent Meningococcal Conjugate Vaccine (MCV4)
Authors: Centers for Disease Control and Prevention
Source: MMWR, May 2, 2008, Vol. 57(17):462-5
HTML  |  PDF (entire issue)
Risk Factors for Meningococcal Disease in Students in Grades 9-12
Authors: Harrison LH, Kreiner CJ, Shutt KA
Source: Pediatr Infect Dis J, March 2008, Vol. 27(3):193-9
Abstract
New, and Some Not-So-New, Vaccines for Adolescents and Diseases They Prevent
Authors: Fishbein DB, Broder KR, Markowitz L, Messonnier N
Source: Pediatrics, January 2008, Vol.121 Suppl 1:S5-14
Abstract
Economics of an Adolescent Meningococcal Conjugate Vaccination Catch-Up Campaign in the United States
Authors: Ortega-Sanchez IR, Meltzer MI, Shepard C
Source: Clin Infect Dis, January 1, 2008, Vol. 46(1):1-13
Abstract
Mass Antibiotic Treatment to Stop an Outbreak of Meningococcal Disease: A Molecular Analysis
Authors: Katz LH, Zelazny A, Scharf S, et al
Source: Clin Microbiol Infect, September 2007; 13(9):943-946
Abstract
Notice to Readers: Revised Recommendations of the Advisory Committee on Immunization Practices to Vaccinate All Persons Aged 11--18 Years with Meningococcal Conjugate Vaccine
Source: MMWR, August 10, 2007; 56(31):794-795
HTML |  PDF (entire issue)
Meningococcal Vaccines: To Eradicate the Disease, not the Bacterium
Authors: Taha MK, Alonso JM
Source: Hum Vaccin, July-August 2007; 3(4):149-153
Abstract
Clonal Waves of Neisseria Colonisation and Disease in the African Meningitis Belt: Eight-Year Longitudinal Study in Northern Ghana
Authors: Leimkugel J, Hodgson A, Forgor AA, et al
Source: PLoS Med, March 27, 2007; 4(3):e101
Abstract
back to top
Meningococcus 2006
General Recommendations on Immunization
Source: MMWR, December 1, 2006; 55(RR-15):1-48
HTML |  PDF (entire issue)
Notice to Readers: Recommendation to resume meningococcal vaccination of children aged 11-12 years
MMWR, November 3, 2006, Vol. 55(43):1177
HTML |  PDF (entire issue)
Prevention of Meningococcal Disease
Author: Gardner P
Source: N Engl J Med, October 5, 2006, Vol. 355: 1466-1473
Click here for free full-text article
PDF
Multicenter Surveillance of Invasive Meningococcal Infections in Children
Authors: Kaplan SL, Schutze GE, Leake JA, et al
Source: Pediatrics, October 2006, Vol. 118(4):e979-984
Abstract
Inadvertent Misadministration of Meningococcal Conjugate Vaccine --- United States, June--August 2005
Source: MMWR, September 22, 2006, Vol. 55(37):1016-1017
HTML |  PDF (entire issue)
Notice to Readers: Limited Supply of Meningococcal Conjugate Vaccine, Recommendation to Defer Vaccination of Persons Aged 11--12 Years
Source: MMWR, May 26, 2006 Vol. 55(20):567-568
HTML |  PDF (entire issue)
Update: Guillain-Barré Syndrome Among Recipients of Menactra® Meningococcal Conjugate Vaccine --- United States, October 2005--February 2006
Source: MMWR, April 7, 2006, Vol. 55(13):364-366
HTML
Antibody Persistence 3 Years after Immunization of Adolescents With Quadrivalent Meningococcal Conjugate Vaccine
Authors: Mitchell P, Dela Cruz JV, Granoff DM et al
Source: J Infect Dis, March 15, 2006, Vol. 193(6):821-882
Abstract
Population-Based Analysis of Meningococcal Disease Mortality in the United States: 1990-2002
Authors: Sharip A, Sorvillo F, Redelings MD, et al
Source: Pediatr Infect Dis J, March 2006, Vol. 25(3):191-194
Abstract
back to top
Meningococcus 2005
Prevention of Meningococcal Disease
Author: Kimmel SR
Source: Am Fam Physician, Nov. 15, 2005, Vol. 72(10):2049-2056
Abstract
Guillain-Barré Syndrome Among Recipients of Menactra® Meningococcal Conjugate Vaccine --- United States, June--July 2005
Source: MMWR, October 14, 2005, Vol. 54(40):1023-1025
HTML
Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, May 27, 2005, Vol. 54(RR07):1-21
PDF
Prevention and Control of Meningococcal Disease: Recommendations for Use of Meningococcal Vaccines in Pediatric Patients
Source: American Academy of Pediatrics, May 25, 2005
PDF
Cost-effectiveness of Conjugate Meningococcal Vaccination Strategies in the United States
Authors: Shepard CW, Ortega-Sanchez IR, Scott RD 2nd, et al
Source: Pediatrics, May 2005, Vol. 115(5):1220-1232
Abstract
Meningococcal Vaccine: New Product, New Recommendations
Author: Campos-Outcalt D
Source: J Fam Pract, April 2005, Vol. 54(4):324-326
Abstract
Comparative Trial of the Safety and Immunogenicity of Quadrivalent (A, C, Y, W-135) Meningococcal Polysaccharide-diphtheria Conjugate Vaccine Versus Quadrivalent Polysaccharide Vaccine in Two- to Ten-year-old Children
Authors: Pichichero M, Casey J, Blatter M, et al
Source: Pediatr Infect Dis J, January 2005, Vol. 24(1):57-62
Abstract
back to top
Meningococcus 2004
Global Epidemiology of Meningococcal Disease and Vaccine Efficacy
Author: Pollard AJ
Source: Pediatr Infect Dis J, December 2004, Vol. 23(12):S274-S279
Abstract
Meningococcal C Vaccines: The Canadian Experience
Author: De Wals P
Source: Pediatr Infect Dis J, December 2004, Vol. 23(12):S280-S284
Abstract
Meningococcal Vaccines
Author: Danzig L
Source: Pediatr Infect Dis J, December 2004, Vol. 23(12):S285-S292
Abstract
The Strategy to Control New Zealand's Epidemic of Group B Meningococcal Disease
Authors: O'Hallahan J, Lennon D, Oster P
Source: Pediatr Infect Dis J, December 2004, Vol. 23(12):S293-S298
Abstract
Cost-effectiveness of Conjugate Meningococcal Vaccination Strategies in the United States
Authors: Shepard CW, Ortega-Sanchez IR, Scott RD 2nd, et al
Source: Pediatrics, May 2005, Vol. 115(5):1220-1232
Abstract
The Rhode Island Meningitis Vaccine Experience--Mass Vaccination Campaigns, Politics and Health Policy
Author: Nolan P
Source: Med Health R I, March 2004, Vol. 87(3):65-67
Abstract
Opportunities for Control of Meningococcal Disease in the United States
Authors: Raghunathan PL, Bernhardt SA, Rosenstein NE
Source: Annu Rev Med, 2004, Vol. 55:333-353
Abstract
back to top
Meningococcus Archive
Meningococcus journal articles 2003-1991
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.